Chinese medicament for treating chronic nephritis

Abstract

The invention belongs to a Chinese medicinal composition, and particularly relates to a Chinese medicament for treating chronic nephritis. The Chinese medicament is prepared from the following raw materials in part by weight: 2 to 4 parts of willow-leaved smartweed, 10 to 12 parts of finger citron, 4 to 6 parts of rangoon-creeper fruit, 2 to 4 parts of chinaberry bark, 4 to 6 parts of pumpkin seed, 2 to 4 parts of bud of hairyvein agrimony, 2 to 4 parts of apocynum, 5 to 10 parts of motherwort, 5 to 10 parts of root of red rooted salvia, 5 to 10 parts of astragalus, 4 to 6 parts of many-flower solomonseal rhizome, 5 to 10 parts of tuckahoe, 2 to 4 parts of dodder seed, 3 to 5 parts of barbed skullcap herb, 2 to 4 parts of pharbitis seed and 3 to 6 parts of reed root. The Chinese medicament has the advantages of no toxic or side effect, good treatment effect, low cost, simple preparation method and convenience for administration, has the effects of activating blood, dissolving stasis, relieving heat, easing pain, promoting urination and diminishing swelling, and has good effect of treating chronic nephritis edema, hematuria and albuminuria, dredging meridians, improving blood circulation, detoxifying, dissolving stasis, diminishing swelling, promoting urination, tonifying kidney, tonifying spleen and enhancing kidney function.

Description

(1) Technical field [0001] The invention belongs to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine for treating chronic nephritis. (2) Background technology [0002] Chronic glomerulonephritis, referred to as chronic nephritis, is characterized by proteinuria, hematuria, hypertension, and edema as the basic clinical manifestations. A group of glomerulopathies of chronic renal failure. Due to the different pathological types and stages of diseases in this group, the main clinical manifestations are different, and the disease manifestations are diverse. Chronic glomerulonephritis is a group of primary glomerular diseases with diffuse or focal inflammatory changes in bilateral glomeruli caused by various reasons, with insidious clinical onset, long course and slow progression the general term for. Most scholars believe that the disease may be caused by various bacterial, viral or protozoan infections through immune mechanisms, inf...

AI Technical Summary

Problems solved by technology

The drugs currently used clinically are mainly hormones, cyclophosphamide, tripterygium glycosides, etc. These drugs have serious toxic and side effects after long-term use, and the cost is very high. Some patients cannot use these drugs because of contraindications